M&A Deal Summary

Boston Scientific Acquires Atritech

On March 3, 2011, Boston Scientific acquired medical products company Atritech from SightLine Partners and Cressey for 375M USD

Acquisition Highlights
  • This is Boston Scientific’s 13th transaction in the Medical Products sector.
  • This is Boston Scientific’s 15th largest (disclosed) transaction.
  • This is Boston Scientific’s 16th transaction in the United States.
  • This is Boston Scientific’s 1st transaction in Minnesota.

M&A Deal Summary
Date 2011-03-03
Target Atritech
Sector Medical Products
Buyer(s) Boston Scientific
Sellers(s) SightLine Partners
Cressey
Deal Type Add-on Acquisition
Deal Value 375M USD

Target

Atritech

Plymouth, Minnesota, United States
website
Atritech, Inc. is a clinical stage medical device company and developed the Watchman (a device to treat atrial fibrillation).

Search 192,510 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Boston Scientific

Marlborough, Massachusetts, United States

website

Category Company
Founded 1979
Sector Medical Products
Employees45,000
Revenue 12.7B USD (2022)
DESCRIPTION
Entrance to Boston Scientific's corporate headquarters in Marlborough, Massachusetts.
Entrance to Boston Scientific's corporate headquarters in Marlborough, Massachusetts.

Boston Scientific is a medical technology company. Boston Scientific's products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. Boston Scientific was founded in 1979 and is based in Marlborough, Massachusetts.

DEAL STATS #
Overall 20 of 62
Sector (Medical Products) 13 of 48
Type (Add-on Acquisition) 20 of 48
State (Minnesota) 1 of 6
Country (United States) 16 of 47
Year (2011) 5 of 5
Size (of disclosed) 15 of 32
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-02-15 ReVascular Therapeutics

Sunnyvale, California, United States

Revascular Therapeutics, Inc. operates as an arterial occlusion treatment company. It develops percutaneous medical devices to reopen occluded vessels. The company develops technology for the intravascular treatment of complex lesions and total occlusions. Revascular Therapeutics, Inc. was incorporated in 1999 and is headquartered in Sunnyvale, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-03-08 Cameron Health

San Clemente, California, United States

Cameron is developing a next generation leadless implantable cardiac defibrillator . Cameron Health company headquartered in San Clemente, California. Founded in 2001, the company has developed the world's first and only commercially available completely subcutaneous ICD (S-ICD System).

Buy $150M

Seller(S) 2

SELLER

SightLine Partners

Bloomington, Minnesota, United States

Investor Investor Investor Investor

website

Category Growth Capital Firm
Founded 2004
Size Small
Type Sector Focused
DESCRIPTION

SightLine Partners is a private investment firm that targets early to late stage investments in growing healthcare and medical technology companies. Depending on the maturity of the company, Sightline will invest between $2 and $8 million per transaction. SightLine prefers US based opportunities. SightLine Partners LLC was formed in 2004 and is based in Minneapolis, Minnesota.

DEAL STATS #
Overall 15 of 16
Sector (Medical Products) 14 of 15
Type (Add-on Acquisition) 12 of 12
State (Minnesota) 4 of 5
Country (United States) 15 of 16
Year (2011) 1 of 1
Size (of disclosed) 1 of 7
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-12-01 Acorn Cardiovascular

St. Paul, Minnesota, United States

Acorn Cardiovascular, Inc. is a medical device company pursuing innovative and effective treatments for patients with heart failure.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-07-02 CVRx

Minneapolis, Minnesota, United States

CVRx is a private medical device company develops implantable technology for the treatment of high blood pressure/hypertension and heart failure to serve customers in Europe. CVRx was founded in 2001 and is based in Minneapolis, Minnesota.

Sell -
SELLER

Cressey

Chicago, Illinois, United States

Investor Investor Investor Investor Investor

website

Category Private Equity Firm
PE ASSETS 1.0B USD
Size Large
Type Sector Focused
DESCRIPTION

Cressey & Company LP is a specialist private equity investment firm focused on buy-and-build opportunities in the healthcare sector. The firm invests in the range of $10 - $100 million and EBITA of at least $5 million. The firm specific areas of interest include hospitals, homecare, outpatient services, and specialty distribution. Types of transaction include buyout, growth and recapitalization. It also seeks controlling interest. Cressey & Company has offices in Chicago, Illinois and Nashville, Tennessee.

DEAL STATS #
Overall 5 of 22
Sector (Medical Products) 2 of 4
Type (Add-on Acquisition) 2 of 11
State (Minnesota) 1 of 1
Country (United States) 4 of 21
Year (2011) 2 of 4
Size (of disclosed) 2 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-03-01 Homecare Homebase

Dallas, Texas, United States

Homecare Homebase LLC is a provider of software services to homecare and hospice providers.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-04-13 Midwest Dental

Mondovi, Wisconsin, United States

Midwest Dental, Inc. is a provider of business management services for dental offices serving communities throughout the Midwest. Dental practices affiliated with Midwest Dental offer a comprehensive range of treatment services including preventive, cosmetic, restorative, and reconstructive dentistry for adults and children. Midwest Dental was formed in 1968 and is based in Mondovi, Wisconsin.

Sell -
Mergr

Product

Company

Legal